InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Thursday, 07/14/2016 9:51:21 AM

Thursday, July 14, 2016 9:51:21 AM

Post# of 232962
I haven't listened to the CC yet, but the general concensus from the board sounds very positive. Still disappointing that adjunct isn't full and monotherapy hasn't started. Great, and unexpected news though that the patient requirements amount was cut in half. That will at least save time and money getting PRO 140 to market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News